{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:27:28Z","timestamp":1792182448955,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Sarcomas account for approximately 10\u201315% of all cancer in children aged\u2009\u2264\u200916. Poorer health-related quality of life (HRQoL) is recorded in comparison to other cancers; however, these studies are limited by generic HRQoL measures not being specific to patients with sarcoma. The aim of this study was to develop paediatric version of the Sarcoma Assessment Measure (SAM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This mixed methods study comprised three stages: item generation, item reduction and establishing content validity. Children aged 8\u201316\u00a0years and parents of children aged 0\u201316\u00a0years with a diagnosis of sarcoma and within 5\u00a0years of completion of treatment were invited to participate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 29 children and 38 parents from three sites participated in the study. Content analysis of the interview transcripts identified 277 post-diagnosis experience statements of which 128 \u2018items\u2019 were included in an Item Reduction Questionnaire, grouped into six domains; physical, disability and inclusion; impact of diagnosis; emotional, impact on family, education. Items with a mean score\u2009&lt;\u20095 and a content validity index of\u2009&lt;\u20090.75 were removed. The final version of SAM-Paeds comprises 33 items (parent version) and 21 items (child version).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study has developed the first disease-specific HRQoL measure for paediatric sarcoma patients. SAM-Paeds is planned for inclusion within international sarcoma clinical trials and will be validated alongside current generic measures. Developed with the same methodology as the adult SAM questionnaire will facilitate the assessment of QoL longitudinally to assess the long-term impact of the diagnosis and treatment of sarcoma in childhood.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41687-025-00857-6","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:09:41Z","timestamp":1741705781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sarcoma Assessment Measure-Paediatric Version (SAM-Paeds): development of a disease-specific patient reported outcome measure for children with sarcoma"],"prefix":"10.1186","volume":"9","author":[{"given":"Rachel M.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie-Anne","family":"Purnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Gerrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriel","family":"Jenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-1149","authenticated-orcid":false,"given":"Madeleine","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"857_CR1","unstructured":"Children, teenagers and young adults UK cancer statistics report 2021. NHS England national disease registration service. https:\/\/digital.nhs.uk\/ndrs\/data\/data-outputs\/ctya-uk-cancer-statistics-report-2021\/cancer-incidence"},{"key":"857_CR2","unstructured":"National Cancer Institute cancer stat facts: Soft tissue including heart cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/soft.html"},{"issue":"6","key":"857_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1367\/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2","volume":"3","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Seid M, Skarr D (2003) The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 3(6):329\u2013341. https:\/\/doi.org\/10.1367\/1539-4409(2003)003%3C;0329:tpaapp%3E;2.0.co;2","journal-title":"Ambul Pediatr"},{"issue":"7","key":"857_CR4","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/cncr.10428","volume":"94","author":"JW Varni","year":"2002","unstructured":"Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P (Apr 2002) The PedsQLTM in pediatric cancer. Cancer 94(7):2090\u20132106. https:\/\/doi.org\/10.1002\/cncr.10428","journal-title":"Cancer"},{"issue":"1","key":"857_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.radonc.2016.05.013","volume":"120","author":"D Leiser","year":"2016","unstructured":"Leiser D et al (Jul 2016) Tumour control and quality of life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy. Radiother Oncol 120(1):163\u2013168. https:\/\/doi.org\/10.1016\/j.radonc.2016.05.013","journal-title":"Radiother Oncol"},{"issue":"3","key":"857_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.brachy.2016.01.001","volume":"15","author":"H Martelli","year":"2016","unstructured":"Martelli H et al (May 2016) Quality of life and functional outcome of male patients with bladder\u2013prostate rhabdomyosarcoma treated with conservative surgery and brachytherapy during childhood. Brachytherapy 15(3):306\u2013311. https:\/\/doi.org\/10.1016\/j.brachy.2016.01.001","journal-title":"Brachytherapy"},{"issue":"1","key":"857_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12955-016-0489-4","volume":"14","author":"JM Giesinger","year":"2016","unstructured":"Giesinger JM et al (Dec 2016) Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain. Health Qual Life Outcomes 14(1):87. https:\/\/doi.org\/10.1186\/s12955-016-0489-4","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"857_CR8","doi-asserted-by":"publisher","first-page":"100047","DOI":"10.1016\/j.esmoop.2021.100047","volume":"6","author":"C Drabbe","year":"2021","unstructured":"Drabbe C et al (Feb 2021) The age-related impact of surviving sarcoma on health-related quality of life: data from the SURVSARC study. ESMO Open 6(1):100047. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100047","journal-title":"ESMO Open"},{"issue":"1","key":"857_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/14737140.2015.972947","volume":"15","author":"KR Gundle","year":"2015","unstructured":"Gundle KR, Cizik AM, Jones RL, Davidson DJ (Jan 2015) Quality of life measures in soft tissue sarcoma. Expert Rev Anticancer Ther 15(1):95\u2013100. https:\/\/doi.org\/10.1586\/14737140.2015.972947","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"857_CR10","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s11136-020-02481-x","volume":"29","author":"A Martins","year":"2020","unstructured":"Martins A et al (Aug 2020) Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM). Qual Life Res 29(8):2287\u20132297. https:\/\/doi.org\/10.1007\/s11136-020-02481-x","journal-title":"Qual Life Res"},{"issue":"6","key":"857_CR11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/cancers16061096","volume":"16","author":"L Hulbert-Williams","year":"2024","unstructured":"Hulbert-Williams L et al (Mar 2024) The Sarcoma Assessment Measure (SAM): preliminary psychometric validation of a novel patient-reported outcome measure. Cancers (Basel) 16(6):1096. https:\/\/doi.org\/10.3390\/cancers16061096","journal-title":"Cancers (Basel)"},{"issue":"23","key":"857_CR12","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1111\/j.1365-2702.2008.02629.x","volume":"17","author":"RM Taylor","year":"2008","unstructured":"Taylor RM, Gibson F, Franck LS (Dec 2008) The experience of living with a chronic illness during adolescence: a critical review of the literature. J Clin Nurs 17(23):3083\u20133091. https:\/\/doi.org\/10.1111\/j.1365-2702.2008.02629.x.","journal-title":"J Clin Nurs"},{"key":"857_CR13","doi-asserted-by":"publisher","unstructured":"Boateng GO, Neilands TB, Frongillo EA, Melgar-Qui\u00f1onez HR, Young SL (Jun 2018) Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health 6. https:\/\/doi.org\/10.3389\/fpubh.2018.00149","DOI":"10.3389\/fpubh.2018.00149"},{"issue":"1","key":"857_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12955-015-0312-7","volume":"13","author":"RM Taylor","year":"2015","unstructured":"Taylor RM et al (Dec 2015) Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer. Health Qual Life Outcomes 13(1):107. https:\/\/doi.org\/10.1186\/s12955-015-0312-7","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"857_CR15","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/pbc.25514","volume":"62","author":"J Stokke","year":"2015","unstructured":"Stokke J, Sung L, Gupta A, Lindberg A, Rosenberg AR (Sep 2015) Systematic review and meta-analysis of objective and subjective quality of life among pediatric, adolescent, and young adult bone tumor survivors. Pediatr Blood Cancer 62(9):1616\u20131629. https:\/\/doi.org\/10.1002\/pbc.25514.","journal-title":"Pediatr Blood Cancer"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/BLO.0b013e31804f545d","volume":"459","author":"JM Frances","year":"2007","unstructured":"Frances JM, Morris CD, Arkader A, Nikolic ZG, Healey JH (Jun 2007) What is quality of life in children with bone Sarcoma? Clin Orthop Relat Res 459: 34\u201339. https:\/\/doi.org\/10.1097\/BLO.0b013e31804f545d","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"857_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7525-12-15","volume":"12","author":"A Br\u00e9dart","year":"2014","unstructured":"Br\u00e9dart A, Marrel A, Abetz-Webb L, Lasch K, Acquadro C (Dec 2014) Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients\u2019 experience. Health Qual Life Outcomes 12(1):15. https:\/\/doi.org\/10.1186\/1477-7525-12-15","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"857_CR18","doi-asserted-by":"publisher","first-page":"e022829","DOI":"10.1136\/bmjopen-2018-022829","volume":"8","author":"S Lorente","year":"2018","unstructured":"Lorente S, Vives J, Viladrich C, Losilla J-M (Jul 2018) Tools to assess the measurement properties of quality of life instruments: a meta-review protocol. BMJ Open 8(7):e022829. https:\/\/doi.org\/10.1136\/bmjopen-2018-022829","journal-title":"BMJ Open"},{"issue":"4","key":"857_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/nur.20199","volume":"30","author":"DF Polit","year":"2007","unstructured":"Polit DF, Beck CT, Owen SV (Aug 2007) Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health 30(4):459\u2013467. https:\/\/doi.org\/10.1002\/nur.20199","journal-title":"Res Nurs Health"},{"issue":"5","key":"857_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/nur.20147","volume":"29","author":"DF Polit","year":"2006","unstructured":"Polit DF, Beck CT (Oct 2006) The content validity index: are you sure you know what\u2019s being reported? critique and recommendations. Res Nurs Health 29(5):489\u2013497. https:\/\/doi.org\/10.1002\/nur.20147","journal-title":"Res Nurs Health"},{"issue":"5","key":"857_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/01.NNR.0000289505.30037.91","volume":"56","author":"LS Schilling","year":"2007","unstructured":"Schilling LS, Dixon JK, Knafl KA, Grey M, Ives B, Lynn MR (Sep 2007) Determining content validity of a self-report instrument for adolescents using a heterogeneous expert panel. Nurs Res 56(5):361\u2013366. https:\/\/doi.org\/10.1097\/01.NNR.0000289505.30037.91","journal-title":"Nurs Res"},{"issue":"11","key":"857_CR22","doi-asserted-by":"publisher","first-page":"e202868","DOI":"10.1001\/jamapediatrics.2020.2868","volume":"174","author":"AB Leahy","year":"2020","unstructured":"Leahy AB, Steineck A (Nov 2020) Patient-reported outcomes in pediatric oncology. JAMA Pediatr 174(11):e202868. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.2868","journal-title":"JAMA Pediatr"},{"issue":"10","key":"857_CR23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00520-009-0660-0","volume":"17","author":"J McDougall","year":"2009","unstructured":"McDougall J, Tsonis M (Oct 2009) Quality of life in survivors of childhood cancer: a systematic review of the literature (2001\u20132008). Support Care Cancer 17(10):1231\u20131246. https:\/\/doi.org\/10.1007\/s00520-009-0660-0","journal-title":"Support Care Cancer"},{"issue":"8","key":"857_CR24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/1055-9965.EPI-20-0076","volume":"29","author":"MW Bishop","year":"2020","unstructured":"Bishop MW et al (Aug 2020) Cumulative Burden of chronic health conditions in adult survivors of Osteosarcoma and Ewing Sarcoma: a Report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol Biomarkers Prev 29(8):1627\u20131638. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0076","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"857_CR25","unstructured":"Common Terminology Criteria for Adverse Events. Version 5.0. Published November 27, 2017. U.S Department of Health and Human Services. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"},{"issue":"1","key":"857_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12904-018-0328-y","volume":"17","author":"J Avoine-Blondin","year":"2018","unstructured":"Avoine-Blondin J et al (Dec 2018) How do professionals assess the quality of life of children with advanced cancer receiving palliative care, and what are their recommendations for improvement? BMC Palliat Care 17(1):71. https:\/\/doi.org\/10.1186\/s12904-018-0328-y","journal-title":"BMC Palliat Care"},{"key":"857_CR27","doi-asserted-by":"publisher","unstructured":"Leahy AB, Feudtner C, Basch E (Apr 2018) Symptom monitoring in pediatric oncology using patient-reported outcomes: why, How, and Where Next. The Patient-Patient-Centered Outcomes Res 11(2):147\u2013153. https:\/\/doi.org\/10.1007\/s40271-017-0279-z","DOI":"10.1007\/s40271-017-0279-z"},{"issue":"15","key":"857_CR28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1200\/JCO.21.02669","volume":"40","author":"DR Freyer","year":"2022","unstructured":"Freyer DR, et al (May 2022) Lack of concordance in symptomatic adverse event reporting by children, clinicians, and caregivers: implications for cancer clinical trials. J Clin Oncol 40(15):1623\u20131634. https:\/\/doi.org\/10.1200\/JCO.21.02669","journal-title":"J Clin Oncol"},{"issue":"3","key":"857_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0345-9","volume":"6","author":"AW Smith","year":"2016","unstructured":"Smith AW et al (Sep 2016) News from the NIH: person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity. Transl Behav Med 6(3):470\u2013474. https:\/\/doi.org\/10.1007\/s13142-015-0345-9","journal-title":"Transl Behav Med"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00857-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00857-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00857-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:09:45Z","timestamp":1741705785000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-025-00857-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00857-6","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the South-Central Hampshire B Research Ethics Committee (19\/SC\/0511).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}